# Therapeutic Advances in Neurological Disorders

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/therapeutic-advances-in-neurological-disorders/

## Facts

| Field | Value |
| --- | --- |
| Open Access | true |
| ISSN-L | 1756-2856 |
| ISSNs | 1756-2856,1756-2864 |
| OpenAlex ID | https://openalex.org/S7261370 |
| Publisher | SAGE Publishing |

## Journal papers

- [Current and future treatments for Alzheimer’s disease](https://scholariq.org/papers/current-and-future-treatments-for-alzheimer-s-disease/)
- [Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)](https://scholariq.org/papers/multiple-sclerosis-therapy-consensus-group-mstcg-position-statement-on-disease/)
- [Sex effects across the lifespan in women with multiple sclerosis](https://scholariq.org/papers/sex-effects-across-the-lifespan-in-women-with-multiple-sclerosis/)
- [Recent advances in treatment for narcolepsy](https://scholariq.org/papers/recent-advances-in-treatment-for-narcolepsy/)
- [Longitudinal treatment responsiveness on plasma neurofilament light chain and glial fibrillary acidic protein levels in neuromyelitis optica spectrum disorder](https://scholariq.org/papers/longitudinal-treatment-responsiveness-on-plasma-neurofilament-light-chain-and/)
- [Diagnosis and management of central hypersomnias](https://scholariq.org/papers/diagnosis-and-management-of-central-hypersomnias/)
- [Rituximab in the treatment of immune-mediated necrotizing myopathy: a review of case reports and case series](https://scholariq.org/papers/rituximab-in-the-treatment-of-immune-mediated-necrotizing-myopathy-a-review-of/)
- [Treatment satisfaction in 5q-spinal muscular atrophy under nusinersen therapy](https://scholariq.org/papers/treatment-satisfaction-in-5q-spinal-muscular-atrophy-under-nusinersen-therapy/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.